446 related articles for article (PubMed ID: 23764846)
21. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
[TBL] [Abstract][Full Text] [Related]
22. Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway.
Miao Y; Li X; Yang Y; Zhang J; Chen L; Zhang Q; Li W; Liu Y; Zhang X; Gu R; Yang C
Int Immunopharmacol; 2022 Dec; 113(Pt B):109427. PubMed ID: 36375321
[TBL] [Abstract][Full Text] [Related]
23. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
[TBL] [Abstract][Full Text] [Related]
24. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
[TBL] [Abstract][Full Text] [Related]
26. Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Li S; Liu Z; Jiao X; Gu J; Liu Z; Meng L; Li W; Zhang T; Liu J; Chai D; Liu J; Yang Z; Liu Y; Jiao R; Li X; Zhou H; Zhang Y
Biochem Pharmacol; 2024 Jul; 225():116282. PubMed ID: 38762147
[TBL] [Abstract][Full Text] [Related]
27. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R
PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376
[TBL] [Abstract][Full Text] [Related]
28. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
Qu Y; Zhang L; Kang Z; Jiang W; Lv C
Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
[TBL] [Abstract][Full Text] [Related]
29. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
30. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.
Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV
J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401
[TBL] [Abstract][Full Text] [Related]
31. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
Deng W; Zhang Y; Fang P; Shi H; Yang S
Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
[TBL] [Abstract][Full Text] [Related]
33. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
34. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
Miao Y; Wang Y; Bi Z; Huang K; Gao J; Li X; Li S; Wei L; Zhou H; Yang C
BMC Pulm Med; 2023 Mar; 23(1):94. PubMed ID: 36949426
[TBL] [Abstract][Full Text] [Related]
35. Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis.
Weng CM; Li Q; Chen KJ; Xu CX; Deng MS; Li T; Zhang DD; Duan ZX; Chen ZQ; Li GH; Chen J; Wang JM
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31868203
[TBL] [Abstract][Full Text] [Related]
36. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
37. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
38. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway.
Ruan H; Luan J; Gao S; Li S; Jiang Q; Liu R; Liang Q; Zhang R; Zhang F; Li X; Zhou H; Yang C
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361644
[TBL] [Abstract][Full Text] [Related]
39. Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study.
Gan C; Zhang Q; Liu H; Wang G; Wang L; Li Y; Tan Z; Yin W; Yao Y; Xie Y; Ouyang L; Yu L; Ye T
Respir Res; 2022 Feb; 23(1):32. PubMed ID: 35172837
[TBL] [Abstract][Full Text] [Related]
40. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
